{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:32:04Z","timestamp":1793367124274,"version":"4.5.0"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.survophthal.2026.10.007","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:05:20Z","timestamp":1792623920000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subretinal fibrosis in neovascular age-related macular degeneration: From clinical features to fibrotic mechanisms and therapeutic opportunities"],"prefix":"10.1016","author":[{"given":"Xieyichang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yike","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.survophthal.2026.10.007_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2023.26074","article-title":"Age-related macular degeneration: a review","volume":"331","author":"Fleckenstein","year":"2024","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.survophthal.2026.10.007_bib2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1159\/000518822","article-title":"Global incidence, progression, and risk factors of age-related macular degeneration and projection of disease statistics in 30 years: a modeling study","volume":"68","author":"Wang","year":"2022","journal-title":"Gerontology"},{"issue":"12","key":"10.1016\/j.survophthal.2026.10.007_bib3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bjo.57.12.951","article-title":"New vessel formation beneath the retinal pigment epithelium in senile eyes","volume":"57","author":"Sarks","year":"1973","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.10.007_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.10.007_bib5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajo.2022.09.008","article-title":"Review of fibrosis in neovascular age-related macular degeneration","volume":"246","author":"Cheong","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2026.10.007_bib6","first-page":"1519","article-title":"Age-related macular degeneration histopathologic studies","volume":"100","author":"Green","year":"1993","journal-title":"1992 Lorenz E Zimm Lect Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.10.007_bib7","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/biom12111629","article-title":"Current and novel therapeutic approaches for treatment of neovascular age-related macular degeneration","volume":"12","author":"ElSheikh","year":"2022","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.survophthal.2026.10.007_bib8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/ceo.13742","article-title":"Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: A single-centre French study","volume":"48","author":"Wolff","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.oret.2020.09.025","article-title":"Principal Cause of Poor Visual Acuity after Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 23","volume":"5","author":"Okeagu","year":"2021","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2026.10.007_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106250","article-title":"Molecular pathogenesis of subretinal fibrosis in neovascular AMD focusing on epithelial-mesenchymal transformation of retinal pigment epithelium","volume":"185","author":"Liu","year":"2023","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.survophthal.2026.10.007_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00441-021-03514-8","article-title":"Subretinal fibrosis in neovascular age-related macular degeneration: current concepts, therapeutic avenues, and future perspectives","volume":"387","author":"Tenbrock","year":"2022","journal-title":"Cell Tissue Res"},{"issue":"2","key":"10.1016\/j.survophthal.2026.10.007_bib12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/NRR.NRR-D-23-01642","article-title":"Subretinal fibrosis secondary to neovascular age-related macular degeneration: mechanisms and potential therapeutic targets","volume":"20","author":"Zhang","year":"2025","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.survophthal.2026.10.007_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ajo.2023.03.033","article-title":"Ten-Year Incidence of Fibrosis and Risk Factors for Its Development in Neovascular Age-Related Macular Degeneration","volume":"252","author":"Romano","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.10.007_bib14","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41433-025-03687-4","article-title":"Factors associated with achieving various visual acuity outcomes during loading doses of aflibercept 2\u2009mg for treatment na\u00efve exudative age-related macular degeneration: PRECISE Study Report 7","volume":"39","author":"Chandak","year":"2025","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2026.10.007_bib15","article-title":"Strongest Correlation Between Contrast Sensitivity and Morphological Characteristics in Bilateral nAMD","volume":"7","author":"Hoffmann","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.survophthal.2026.10.007_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.9.4.13","article-title":"Subretinal Fibrosis Detection Using Polarization Sensitive Optical Coherence Tomography","volume":"9","author":"Gr\u00e4fe","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.10.007_bib17","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1097\/IAE.0000000000000819","article-title":"OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF SUBRETINAL FIBROSIS IN AGE-RELATED MACULAR DEGENERATION","volume":"35","author":"Miere","year":"2015","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.survophthal.2026.10.007_bib18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.oret.2020.11.006","article-title":"Stages of Drusen-Associated Atrophy in Age-Related Macular Degeneration Visible via Histologically Validated Fundus Autofluorescence","volume":"5","author":"Chen","year":"2021","journal-title":"Ophthalmol Retin"},{"issue":"11","key":"10.1016\/j.survophthal.2026.10.007_bib19","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.oret.2021.01.012","article-title":"Fundus Autofluorescence in Neovascular Age-Related Macular Degeneration: A Clinicopathologic Correlation Relevant to Macular Atrophy","volume":"5","author":"Chen","year":"2021","journal-title":"Ophthalmol Retin"},{"issue":"3","key":"10.1016\/j.survophthal.2026.10.007_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.survophthal.2023.10.013","article-title":"Subretinal hyperreflective material in retinal and chorioretinal disorders: A comprehensive review","volume":"69","author":"Feo","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.10.007_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajo.2016.06.031","article-title":"Subretinal Hyperreflective Material Imaged With Optical Coherence Tomography Angiography","volume":"169","author":"Dansingani","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcjo.2024.05.007","article-title":"Subretinal hyperreflective material in regions of atrophy and fibrosis in eyes with neovascular age-related macular degeneration","volume":"60","author":"Lindenberg","year":"2025","journal-title":"Can J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.10.007_bib23","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1007\/s00417-018-4121-7","article-title":"Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography","volume":"256","author":"Maruyama-Inoue","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.10.007_bib24","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/IAE.0000000000000166","article-title":"SUBRETINAL HYPERREFLECTIVE EXUDATION ASSOCIATED WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION","volume":"34","author":"Shah","year":"2014","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.survophthal.2026.10.007_bib25","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.ophtha.2015.05.042","article-title":"Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"122","author":"Willoughby","year":"2015","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2026.10.007_bib26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.oret.2019.06.002","article-title":"The Evolution of Fibrosis and Atrophy and Their Relationship with Visual Outcomes in Asian Persons with Neovascular Age-Related Macular Degeneration","volume":"3","author":"Cheung","year":"2019","journal-title":"Ophthalmol Retin"},{"issue":"2","key":"10.1016\/j.survophthal.2026.10.007_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.101027","article-title":"Standardization of Imaging Criteria for Detecting Macular Fibrosis in Neovascular Age-Related Macular Degeneration","volume":"6","author":"Chakravarthy","year":"2026","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.survophthal.2026.10.007_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ajo.2025.01.011","article-title":"Agreement Between Color, Fluorescein Angiography, and Spectral Domain Optical Coherence Tomography in the Detection of Macular Fibrosis in Neovascular Age-Related Macular Degeneration","volume":"272","author":"Csincsik","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.10.007_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2020.02.016","article-title":"Spectral-Domain Optical Coherence Tomography Analysis of Fibrotic Lesions in Neovascular Age-Related Macular Degeneration","volume":"214","author":"Souied","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib30","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1038\/s41598-020-64601-4","article-title":"Polarization-sensitive optical coherence tomography for estimating relative melanin content of autologous induced stem-cell derived retinal pigment epithelium","volume":"10","author":"Matsuzaki","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.survophthal.2026.10.007_bib31","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1364\/BOE.426650","article-title":"Identification and quantification of fibrotic areas in the human retina using polarization-sensitive OCT","volume":"12","author":"Motschi","year":"2021","journal-title":"Biomed Opt Express"},{"issue":"4","key":"10.1016\/j.survophthal.2026.10.007_bib32","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/jcm13041074","article-title":"Structure-Function Correlation of Retinal Fibrosis in Eyes with Neovascular Age-Related Macular Degeneration","volume":"13","author":"Schranz","year":"2024","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.survophthal.2026.10.007_bib33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41684-024-01408-0","article-title":"In vivo monitoring of active subretinal fibrosis in mice using collagen hybridizing peptides","volume":"53","author":"Linder","year":"2024","journal-title":"Lab Anim (NY)"},{"issue":"3","key":"10.1016\/j.survophthal.2026.10.007_bib34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","article-title":"Risk of scar in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Daniel","year":"2014","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.survophthal.2026.10.007_bib35","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/jamaophthalmol.2020.3001","article-title":"Associations of Variation in Retinal Thickness With Visual Acuity and Anatomic Outcomes in Eyes With Neovascular Age-Related Macular Degeneration Lesions Treated With Anti\u2013Vascular Endothelial Growth Factor Agents","volume":"138","author":"Evans","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.10.007_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.oret.2023.12.012","article-title":"Improved Structure and Function in Early-Detected Second-Eye Neovascular Age-Related Macular Degeneration: FASBAT\/Early Detection of Neovascular Age-Related Macular Degeneration Report 1","volume":"8","author":"Gale","year":"2024","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2026.10.007_bib37","article-title":"Analysis of factors affecting prognosis of the visual acuity and baseline risk factors for subretinal fibrosis in neovascular age-related macular degeneration patients","volume":"11","author":"Liu","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"10.1016\/j.survophthal.2026.10.007_bib38","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/IAE.0000000000002779","article-title":"PREVALENCE AND RISK FACTORS FOR THE DEVELOPMENT OF PHYSICIAN-GRADED SUBRETINAL FIBROSIS IN EYES TREATED FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION","volume":"40","author":"Teo","year":"2020","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.survophthal.2026.10.007_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.oret.2017.08.019","article-title":"Tomographic Biomarkers Predicting Progression to Fibrosis in Treated Neovascular Age-Related Macular Degeneration: A Multimodal Imaging Study","volume":"2","author":"Casalino","year":"2018","journal-title":"Ophthalmol Retin"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1167\/iovs.18-25189","article-title":"Identification and Quantification of the Angiofibrotic Switch in Neovascular AMD","volume":"60","author":"Roberts","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.survophthal.2026.10.007_bib41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.oret.2022.03.024","article-title":"Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials","volume":"6","author":"Core","year":"2022","journal-title":"Ophthalmol Retin"},{"issue":"16","key":"10.1016\/j.survophthal.2026.10.007_bib42","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1038\/s41433-024-03256-1","article-title":"Effect of baseline fluid localization on visual acuity and prognosis in type 1 macular neovascularization treated with anti-VEGF","volume":"38","author":"Gadiollet","year":"2024","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.survophthal.2026.10.007_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/aos.15233","article-title":"Association between structural and functional treatment outcomes in neovascular age-related macular degeneration","volume":"101","author":"Haji","year":"2023","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.10.007_bib44","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1111\/aos.14905","article-title":"The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world","volume":"100","author":"Llorente-Gonz\u00e1lez","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.10.007_bib45","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/ceo.13949","article-title":"Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry","volume":"49","author":"Nguyen","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41598-021-03716-8","article-title":"Baseline predictors for subretinal fibrosis in neovascular age-related macular degeneration","volume":"12","author":"Roberts","year":"2022","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.survophthal.2026.10.007_bib47","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/aos.14786","article-title":"Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study","volume":"99","author":"Saenz-de-Viteri","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.10.007_bib48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/aos.15309","article-title":"Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5\u2009years of follow-up from Fight Retinal Blindness registry","volume":"101","author":"S\u00e1nchez-Monroy","year":"2023","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.10.007_bib49","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jcjo.2023.10.017","article-title":"Long-term effect of fluid volumes during the maintenance phase in neovascular age-related macular degeneration: results from Fight Retinal Blindness!","volume":"59","author":"Reiter","year":"2024","journal-title":"Can J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.10.007_bib50","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.oret.2024.05.019","article-title":"Quantitative Multimodal Imaging Characterization of Intraretinal Cysts versus Degenerative Pseudocysts in Neovascular Age-Related Macular Degeneration","volume":"8","author":"Arrigo","year":"2024","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.survophthal.2026.10.007_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajo.2021.09.033","article-title":"Associations and Outcomes of Patients with Submacular Hemorrhage Secondary to Age-related Macular Degeneration in the IVAN Trial","volume":"236","author":"Mehta","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25860-5","article-title":"Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2026.10.007_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108417","article-title":"Multimodal imaging and electroretinography highlights the role of VEGF in the laser-induced subretinal fibrosis of monkey","volume":"203","author":"Wang","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2026.10.007_bib54","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajo.2020.11.002","article-title":"Localized Optical Coherence Tomography Precursors of Macular Atrophy and Fibrotic Scar in the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"223","author":"Finn","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.10.007_bib55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/iovs.65.6.30","article-title":"Quantitative Optical Coherence Tomography Detection of New Neovascular Branches and Association With Exudation Recurrence in Neovascular Age-Related Macular Degeneration","volume":"65","author":"Arrigo","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2026.10.007_bib56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40123-025-01093-3","article-title":"To Treat or Not to Treat? Resolving the Question of Subretinal and Intraretinal Fluid in Age-Related Macular Degeneration: A Narrative Review","volume":"14","author":"Foss","year":"2025","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"10.1016\/j.survophthal.2026.10.007_bib57","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1111\/aos.16759","article-title":"Subretinal fibrosis occurrence according to macular neovascularisation subtypes in neovascular age-related macular degeneration","volume":"103","author":"Lenhof","year":"2025","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.10.007_bib58","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.oret.2020.02.012","article-title":"Subretinal Fibrosis in HARBOR Varies by Choroidal Neovascularization Subtype","volume":"4","author":"Adrean","year":"2020","journal-title":"Ophthalmol Retin"},{"issue":"4","key":"10.1016\/j.survophthal.2026.10.007_bib59","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3390\/jcm9041145","article-title":"Long-Term Treatment Outcomes in Type 3 Neovascularization: Focus on the Difference in Outcomes between Geographic Atrophy and Fibrotic Scarring","volume":"9","author":"Kim","year":"2020","journal-title":"JCM"},{"issue":"9","key":"10.1016\/j.survophthal.2026.10.007_bib60","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bjo-2023-324713","article-title":"Predictors of 24-month onset of macular fibrosis in type 3 macular neovascularisation","volume":"108","author":"Forte","year":"2024","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.10.007_bib61","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/iovs.65.3.18","article-title":"Distinct Pathways of Macular Atrophy in Type 3 Macular Neovascularization Associated With AMD","volume":"65","author":"Borrelli","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.survophthal.2026.10.007_bib62","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/bjo-2022-323014","article-title":"Approved AI-based fluid monitoring to identify morphological and functional treatment outcomes in neovascular age-related macular degeneration in real-world routine","volume":"108","author":"Mares","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.10.007_bib63","article-title":"Imaging and functional correlates of fibrosis in neovascular age-related macular degeneration: a systematic review","volume":"6","author":"Spooner","year":"2026","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"10.1016\/j.survophthal.2026.10.007_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109428","article-title":"Animal model of subretinal fibrosis without active choroidal neovascularization","volume":"229","author":"Zandi","year":"2023","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2026.10.007_bib65","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.exer.2019.04.027","article-title":"Effects of intravitreal connective tissue growth factor neutralizing antibody on choroidal neovascular membrane-associated subretinal fibrosis","volume":"184","author":"Daftarian","year":"2019","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.survophthal.2026.10.007_bib66","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2174\/1567202617666200523163636","article-title":"Anti-vascular Endothelial Growth Factor Antibody Limits the Vascular Leakage and Decreases Subretinal Fibrosis in a Cynomolgus Monkey Choroidal Neovascularization Model","volume":"17","author":"Inagaki","year":"2020","journal-title":"CNR"},{"issue":"4","key":"10.1016\/j.survophthal.2026.10.007_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.9.4.3","article-title":"A Two-Stage Laser-Induced Mouse Model of Subretinal Fibrosis Secondary to Choroidal Neovascularization","volume":"9","author":"Little","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.10.007_bib68","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1167\/iovs.10-5189","article-title":"Establishment of a new animal model of focal subretinal fibrosis that resembles disciform lesion in advanced age-related macular degeneration","volume":"52","author":"Jo","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.survophthal.2026.10.007_bib69","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1167\/iovs.09-4956","article-title":"A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap","volume":"51","author":"Cao","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2026.10.007_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.580884","article-title":"Fenofibrate Inhibits Subretinal Fibrosis Through Suppressing TGF-\u03b2-Smad2\/3 signaling and Wnt signaling in Neovascular Age-Related Macular Degeneration","volume":"11","author":"Chen","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66068-z","article-title":"JR5558 mice are a reliable model to investigate subretinal fibrosis","volume":"14","author":"Seyed-Razavi","year":"2024","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.survophthal.2026.10.007_bib72","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/nprot.2013.135","article-title":"Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice","volume":"8","author":"Lambert","year":"2013","journal-title":"Nat Protoc"},{"issue":"9","key":"10.1016\/j.survophthal.2026.10.007_bib73","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3390\/biomedicines11092445","article-title":"Neovascular Progression and Retinal Dysfunction in the Laser-Induced Choroidal Neovascularization Mouse Model","volume":"11","author":"Salas","year":"2023","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.survophthal.2026.10.007_bib74","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1167\/iovs.14-13989","article-title":"Spontaneous CNV in a Novel Mutant Mouse Is Associated With Early VEGF-A\u2013Driven Angiogenesis and Late-Stage Focal Edema, Neural Cell Loss, and Dysfunction","volume":"55","author":"Nagai","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2026.10.007_bib75","first-page":"745","article-title":"Green WR. Histopathologic and ultrastructural findings of surgically excised choroidal neovascularization","volume":"116","author":"Grossniklaus","year":"1998","journal-title":"Submacular Surg Trials Res Group Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.10.007_bib76","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ebiom.2018.11.029","article-title":"Myofibroblasts in macular fibrosis secondary to neovascular age-related macular degeneration - the potential sources and molecular cues for their recruitment and activation","volume":"38","author":"Little","year":"2018","journal-title":"eBioMedicine"},{"issue":"Pt 4","key":"10.1016\/j.survophthal.2026.10.007_bib77","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/eye.1997.137","article-title":"Morphology of early choroidal neovascularisation in age-related macular degeneration: correlation with activity","volume":"11","author":"Sarks","year":"1997","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2026.10.007_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.916719","article-title":"Immune Cells in Subretinal Wound Healing and Fibrosis","volume":"16","author":"Szczepan","year":"2022","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"10.1016\/j.survophthal.2026.10.007_bib79","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105123","article-title":"Mapping the origin and fate of myeloid cells in distinct compartments of the eye by single-cell profiling","volume":"40","author":"Wieghofer","year":"2021","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib80","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12974-022-02546-3","article-title":"Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells","volume":"19","author":"Llori\u00e1n-Salvador","year":"2022","journal-title":"J Neuroinflamm"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib81","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s12974-020-02033-7","article-title":"Macrophage to myofibroblast transition contributes to subretinal fibrosis secondary to neovascular age-related macular degeneration","volume":"17","author":"Little","year":"2020","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.survophthal.2026.10.007_bib82","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3389\/fimmu.2018.01002","article-title":"Complement Activation During Ischemia\/Reperfusion Injury Induces Pericyte-to-Myofibroblast Transdifferentiation Regulating Peritubular Capillary Lumen Reduction Through pERK Signaling","volume":"9","author":"Castellano","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib83","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12974-023-02731-y","article-title":"Old age promotes retinal fibrosis in choroidal neovascularization through circulating fibrocytes and profibrotic macrophages","volume":"20","author":"Yi","year":"2023","journal-title":"J Neuroinflamm"},{"issue":"5","key":"10.1016\/j.survophthal.2026.10.007_bib84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3892\/ijmm.2024.5369","article-title":"Role of microglia\/macrophage polarisation in intraocular diseases (Review)","volume":"53","author":"Li","year":"2024","journal-title":"Int J Mol Med"},{"issue":"7","key":"10.1016\/j.survophthal.2026.10.007_bib85","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1681\/ASN.2016050573","article-title":"Macrophage-to-Myofibroblast Transition Contributes to Interstitial Fibrosis in Chronic Renal Allograft Injury","volume":"28","author":"Wang","year":"2017","journal-title":"JASN"},{"issue":"2","key":"10.1016\/j.survophthal.2026.10.007_bib86","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/15548627.2022.2069437","article-title":"Autophagy in age-related macular degeneration","volume":"19","author":"Kaarniranta","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.survophthal.2026.10.007_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2022.983151","article-title":"Scribble basal polarity acquisition in RPE cells and its mislocalization in a pathological AMD-like model","volume":"16","author":"Segurado","year":"2022","journal-title":"Front Neuroanat"},{"issue":"6","key":"10.1016\/j.survophthal.2026.10.007_bib88","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1177\/1120672120919337","article-title":"Bruch\u2019s membrane pathology: A mechanistic perspective","volume":"30","author":"Murali","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib89","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s11658-025-00732-8","article-title":"Potential of autophagy in subretinal fibrosis in neovascular age-related macular degeneration","volume":"30","author":"Blasiak","year":"2025","journal-title":"Cell Mol Biol Lett"},{"issue":"7","key":"10.1016\/j.survophthal.2026.10.007_bib90","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/cells10071587","article-title":"Epithelial-Mesenchymal Transition (EMT): The Type-2 EMT in Wound Healing, Tissue Regeneration and Organ Fibrosis","volume":"10","author":"Marconi","year":"2021","journal-title":"Cells"},{"issue":"21","key":"10.1016\/j.survophthal.2026.10.007_bib91","doi-asserted-by":"crossref","first-page":"11748","DOI":"10.3390\/ijms222111748","article-title":"Understanding Drivers of Ocular Fibrosis: Current and Future Therapeutic Perspectives","volume":"22","author":"Mallone","year":"2021","journal-title":"IJMS"},{"issue":"3","key":"10.1016\/j.survophthal.2026.10.007_bib92","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1080\/15548627.2022.2109286","article-title":"Mitophagy initiates retrograde mitochondrial-nuclear signaling to guide retinal pigment cell heterogeneity","volume":"19","author":"Datta","year":"2023","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib93","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s42003-024-06773-7","article-title":"Deficient RPE mitochondrial energetics leads to subretinal fibrosis in age-related neovascular macular degeneration","volume":"7","author":"Ma","year":"2024","journal-title":"Commun Biol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.10.007_bib94","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.bbadis.2016.05.023","article-title":"Regulation of angiogenin expression and epithelial-mesenchymal transition by HIF-1\u03b1 signaling in hypoxic retinal pigment epithelial cells","volume":"1862","author":"Lai","year":"2016","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"2","key":"10.1016\/j.survophthal.2026.10.007_bib95","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1096\/fj.201801227R","article-title":"Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelialmesenchymal transition","volume":"33","author":"Wu","year":"2019","journal-title":"FASEB J"},{"issue":"11","key":"10.1016\/j.survophthal.2026.10.007_bib96","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3390\/biomedicines12112649","article-title":"Involvement of Lgals3\/Galectin-3 in Choroidal Neovascularization and Subretinal Fibrosis Formation","volume":"12","author":"Wu","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib97","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1038\/s41598-020-60785-x","article-title":"Oxidative stress enhanced the transforming growth factor-\u03b22-induced epithelial-mesenchymal transition through chemokine ligand 1 on ARPE-19 cell","volume":"10","author":"Yang","year":"2020","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.survophthal.2026.10.007_bib98","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101334R","article-title":"Soluble very low-density lipoprotein receptor (sVLDLR) inhibits fibrosis in neovascular age-related macular degeneration","volume":"35","author":"Ma","year":"2021","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12974-024-03068-w","article-title":"Wnt5a\/\u03b2-catenin-mediated epithelial-mesenchymal transition: a key driver of subretinal fibrosis in neovascular age-related macular degeneration","volume":"21","author":"Liu","year":"2024","journal-title":"J Neuroinflamm"},{"issue":"6","key":"10.1016\/j.survophthal.2026.10.007_bib100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/iovs.66.6.30","article-title":"RAGE Is Essential for Subretinal Fibrosis in Laser-Induced Choroidal Neovascularization: Therapeutic Implications","volume":"66","author":"Sreekumar","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13036-020-00235-4","article-title":"Acute mechanical stress in primary porcine RPE cells induces angiogenic factor expression and in vitro angiogenesis","volume":"14","author":"Farjood","year":"2020","journal-title":"J Biol Eng"},{"key":"10.1016\/j.survophthal.2026.10.007_bib102","doi-asserted-by":"crossref","unstructured":"Wang Y., Chen Y., Liang J., 2023. METTL3-mediated m6A modification of HMGA2 mRNA promotes subretinal fibrosis and epithelial\u2013mesenchymal transition. Shen Z., editor. Journal of Molecular Cell Biology. 2023 Aug 3;15(3):mjad005. doi:10.1093\/jmcb\/mjad005.","DOI":"10.1093\/jmcb\/mjad005"},{"issue":"9","key":"10.1016\/j.survophthal.2026.10.007_bib103","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1136\/bjophthalmol-2021-319115","article-title":"Sphingosine 1-phosphate, a potential target in neovascular retinal disease","volume":"106","author":"Alshaikh","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.10.007_bib104","doi-asserted-by":"crossref","first-page":"189","DOI":"10.18240\/ijo.2022.02.01","article-title":"Inhibitory effect on subretinal fibrosis by anti-placental growth factor treatment in a laser-induced choroidal neovascularization model in mice","volume":"15","author":"Zhang","year":"2022","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12979-023-00389-x","article-title":"Vascular Cell Adhesion Molecule-1 (VCAM-1) contributes to macular fibrosis in neovascular age-related macular degeneration through modulating macrophage functions","volume":"20","author":"Deng","year":"2023","journal-title":"Immun Ageing"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib106","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12974-022-02433-x","article-title":"Macrophage elastase (MMP12) critically contributes to the development of subretinal fibrosis","volume":"19","author":"Yi","year":"2022","journal-title":"J Neuroinflamm"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib107","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12967-025-06173-3","article-title":"Targeting macrophage to myofibroblast transition by circ_0001103 for subretinal fibrosis treatment","volume":"23","author":"Zhang","year":"2025","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.survophthal.2026.10.007_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113221","article-title":"YAP is critical to inflammation, endothelial-mesenchymal transition and subretinal fibrosis in experimental choroidal neovascularization","volume":"417","author":"Yang","year":"2022","journal-title":"Exp Cell Res"},{"issue":"5","key":"10.1016\/j.survophthal.2026.10.007_bib109","doi-asserted-by":"crossref","first-page":"701","DOI":"10.18240\/ijo.2022.05.03","article-title":"Yes-associated protein promotes endothelial-to-mesenchymal transition of endothelial cells in choroidal neovascularization fibrosis","volume":"15","author":"Zou","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.10.007_bib110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bcp.2019.04.016","article-title":"Pharmacological inhibition of \u03b2-catenin prevents EndMT in vitro and vascular remodeling in vivo resulting from endothelial Akt1 suppression","volume":"164","author":"Sabbineni","year":"2019","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.10.007_bib111","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14443","article-title":"circSIRT2\/miR-542-3p\/VASH1 axis regulates endothelial-to-mesenchymal transition (EndMT) in subretinal fibrosis in age-related macular degeneration models","volume":"24","author":"Zhang","year":"2025","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.survophthal.2026.10.007_bib112","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10456-018-9614-9","article-title":"SNAI1, an endothelial\u2013mesenchymal transition transcription factor, promotes the early phase of ocular neovascularization","volume":"21","author":"Sun","year":"2018","journal-title":"Angiogenesis"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib113","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12967-026-07707-z","article-title":"Senescence-induced endothelial-to-mesenchymal transition accelerates the subretinal fibrosis in neovascualr age-related macular degeneration","volume":"24","author":"Wang","year":"2026","journal-title":"J Transl Med"},{"issue":"7","key":"10.1016\/j.survophthal.2026.10.007_bib114","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.3390\/jcm9072242","article-title":"Blockade of Platelet-Derived Growth Factor Signaling Inhibits Choroidal Neovascularization and Subretinal Fibrosis in Mice","volume":"9","author":"Liu","year":"2020","journal-title":"JCM"},{"issue":"5","key":"10.1016\/j.survophthal.2026.10.007_bib115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s12276-022-00778-0","article-title":"TGF-\u03b2 promotes pericyte-myofibroblast transition in subretinal fibrosis through the Smad2\/3 and Akt\/mTOR pathways","volume":"54","author":"Zhao","year":"2022","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib116","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1038\/s41467-023-43226-x","article-title":"Epidermal growth factor receptor activation is essential for kidney fibrosis development","volume":"14","author":"Cao","year":"2023","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.survophthal.2026.10.007_bib117","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/cbin.11809","article-title":"Silencing of YAP attenuates pericyte-myofibroblast transition and subretinal fibrosis in experimental model of choroidal neovascularization","volume":"46","author":"Xu","year":"2022","journal-title":"Cell Biol Int"},{"issue":"4","key":"10.1016\/j.survophthal.2026.10.007_bib118","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/glia.23727","article-title":"Glia of the human retina","volume":"68","author":"Reichenbach","year":"2020","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.survophthal.2026.10.007_bib119","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3390\/cells10061339","article-title":"Harnessing Astrocytes and M\u00fcller Glial Cells in the Retina for Survival and Regeneration of Retinal Ganglion Cells","volume":"10","author":"Yoo","year":"2021","journal-title":"Cells"},{"issue":"14","key":"10.1016\/j.survophthal.2026.10.007_bib120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/iovs.61.14.29","article-title":"Involvement of M\u00fcller Glial Autoinduction of TGF-\u03b2 in Diabetic Fibrovascular Proliferation Via Glial\u2013Mesenchymal Transition","volume":"61","author":"Wu","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2026.10.007_bib121","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/jnr.25158","article-title":"Peptidyl arginine deiminase 4 deficiency protects against subretinal fibrosis by inhibiting M\u00fcller glial hypercitrullination","volume":"101","author":"Palko","year":"2023","journal-title":"J Neurosci Res"},{"issue":"9","key":"10.1016\/j.survophthal.2026.10.007_bib122","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2121875119","article-title":"Compartmentalized citrullination in Muller glial endfeet during retinal degeneration","volume":"119","author":"Palko","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2026.10.007_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112261","article-title":"siRASA1 in vascular endothelial cells alleviates subretinal fibrosis through inhibiting macrophage-myofibroblast transdifferentiation via SHH signaling pathway","volume":"138","author":"Jiang","year":"2026","journal-title":"Cell Signal"},{"key":"10.1016\/j.survophthal.2026.10.007_bib124","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3389\/fimmu.2020.00883","article-title":"The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis","volume":"11","author":"Alyaseer","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.survophthal.2026.10.007_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2024.102448","article-title":"The complement pathway as a therapeutic target for neovascular age-related macular degeneration-mediated subretinal fibrosis","volume":"76","author":"Xu","year":"2024","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.survophthal.2026.10.007_bib126","article-title":"Mingjing granule inhibits the subretinal fibrovascular membrane of two-stage laser-induced neovascular age-related macular degeneration in rats","volume":"15","author":"Li","year":"2024","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib127","article-title":"Alpinumisoflavone ameliorates choroidal neovascularisation and fibrosis in age-related macular degeneration in in vitro and in vivo models","volume":"12","author":"Yu","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib128","article-title":"Targeting the VEGFR2 signaling pathway for angiogenesis and fibrosis regulation in neovascular age-related macular degeneration","volume":"14","author":"Yu","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib129","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/s41598-022-04845-4","article-title":"Transcriptomic analysis of choroidal neovascularization reveals dysregulation of immune and fibrosis pathways that are attenuated by a novel anti-fibrotic treatment","volume":"12","author":"Brandli","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.survophthal.2026.10.007_bib130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1167\/iovs.66.6.56","article-title":"Liposome Encapsulation Enhances Ripasudil Therapeutic Efficacy Against Proliferative Vitreoretinal Diseases: Implications in Advanced Ocular Treatment","volume":"66","author":"Ji","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2026.10.007_bib131","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ajpath.2020.12.012","article-title":"Adrenomedullin-Receptor Activity-Modifying Protein 2 System Ameliorates Subretinal Fibrosis by Suppressing Epithelial-Mesenchymal Transition in Age-Related Macular Degeneration","volume":"191","author":"Tanaka","year":"2021","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.10.007_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2022.100038","article-title":"Role of Adrenomedullin 2\/Intermedin in the Pathogenesis of Neovascular Age-Related Macular Degeneration","volume":"103","author":"Kakihara","year":"2023","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib133","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90618-4","article-title":"Inhibition of epithelial-mesenchymal transition in retinal pigment epithelial cells by a retinoic acid receptor-\u03b1 agonist","volume":"11","author":"Kobayashi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2026.10.007_bib134","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8846708","article-title":"Pirfenidone Alleviates Choroidal Neovascular Fibrosis through TGF-\u03b2\/Smad Signaling Pathway","volume":"2021","author":"Gao","year":"2021","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.10.007_bib135","doi-asserted-by":"crossref","unstructured":"Li H., Wang L., Shao M., et al. Pirfenidone Attenuates the EMT Process and the Secretion of VEGF in TGF- \u03b2 2\u2013Induced ARPE-19 Cells via Inhibiting the Activation of the NF- \u03ba B\/Snail Signaling Pathway. Ahmadieh H., ed.itor. Journal of Ophthalmology. 2023 Jan;2023(1):4798071. doi:10.1155\/2023\/4798071.","DOI":"10.1155\/2023\/4798071"},{"key":"10.1016\/j.survophthal.2026.10.007_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154865","article-title":"Luteolin inhibits subretinal fibrosis and epithelial-mesenchymal transition in laser-induced mouse model via suppression of Smad2\/3 and YAP signaling","volume":"116","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.survophthal.2026.10.007_bib137","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1167\/iovs.66.4.83","article-title":"AZGP1 Attenuates Subretinal Fibrosis and Inhibits Epithelial-Mesenchymal Transition by Blocking the PI3K\/AKT Signaling Pathway","volume":"66","author":"Yang","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2026.10.007_bib138","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3892\/ijmm.2025.5486","article-title":"Klotho attenuates epithelial\u2011mesenchymal transition of retinal pigment epithelial cells in subretinal fibrosis by suppressing the ERK1\/2 and Wnt\/\u03b2\u2011catenin signaling pathways","volume":"55","author":"Jiang","year":"2025","journal-title":"Int J Mol Med"},{"issue":"7","key":"10.1016\/j.survophthal.2026.10.007_bib139","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4239\/wjd.v14.i7.1027","article-title":"Klotho: A new therapeutic target in diabetic retinopathy?","volume":"14","author":"Puddu","year":"2023","journal-title":"World J Diabetes"},{"issue":"8","key":"10.1016\/j.survophthal.2026.10.007_bib140","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3390\/cells12081155","article-title":"IKK\u03b2 Inhibition Attenuates Epithelial Mesenchymal Transition of Human Stem Cell-Derived Retinal Pigment Epithelium","volume":"12","author":"Sripathi","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.survophthal.2026.10.007_bib141","doi-asserted-by":"crossref","unstructured":"Im S., Han J.W., Park E.J., 2022. Suppression of choroidal neovascularization and epithelial-mesenchymal transition in retinal pigmented epithelium by adeno-associated virus-mediated overexpression of CCN5 in mice. Jadeja R., editor. PLoS ONE. 2022 June 13;17(6):e0269937. doi:10.1371\/journal.pone.0269937.","DOI":"10.1371\/journal.pone.0269937"},{"issue":"25","key":"10.1016\/j.survophthal.2026.10.007_bib142","first-page":"00355","article-title":"JAM-C prevents ocular fibrosis by suppressing the TAZ\/KLF6 pathway","volume":"19","author":"Chen","year":"2025","journal-title":"J Adv Res"},{"issue":"15","key":"10.1016\/j.survophthal.2026.10.007_bib143","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.3390\/ijms26157131","article-title":"Nintedanib Induces Mesenchymal-to-Epithelial Transition and Reduces Subretinal Fibrosis Through Metabolic Reprogramming","volume":"26","author":"Hughes","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.survophthal.2026.10.007_bib144","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/jop.2019.0112","article-title":"3-Methyladenine Alleviates Experimental Subretinal Fibrosis by Inhibiting Macrophages and M2 Polarization Through the PI3K\/Akt Pathway","volume":"36","author":"Bo","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.survophthal.2026.10.007_bib145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1167\/iovs.66.6.47","article-title":"NR4A1 Alleviates Subretinal Fibrosis by Inhibiting Macrophage to Myofibroblast Transition","volume":"66","author":"Yang","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.survophthal.2026.10.007_bib146","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/jcmm.17730","article-title":"Lycopene inhibits endothelial-to-mesenchymal transition of choroidal vascular endothelial cells in laser-induced mouse choroidal neovascularization","volume":"27","author":"Li","year":"2023","journal-title":"J Cell Mol Med"},{"issue":"737","key":"10.1016\/j.survophthal.2026.10.007_bib147","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk3868","article-title":"Inactivation of adenosine receptor 2A suppresses endothelial-to-mesenchymal transition and inhibits subretinal fibrosis in mice","volume":"16","author":"Yang","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.survophthal.2026.10.007_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153747","article-title":"Intravitreal injection of triptolide attenuates subretinal fibrosis in laser-induced murine model","volume":"93","author":"Lai","year":"2021","journal-title":"Phytomedicine"},{"issue":"9","key":"10.1016\/j.survophthal.2026.10.007_bib149","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.3390\/ijms22094701","article-title":"Suppression of PGC-1\u03b1 Drives Metabolic Dysfunction in TGF\u03b22-Induced EMT of Retinal Pigment Epithelial Cells","volume":"22","author":"Shu","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.survophthal.2026.10.007_bib150","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400540RRR","article-title":"Inhibition of hypoxia-inducible factors suppresses subretinal fibrosis","volume":"38","author":"Shoda","year":"2024","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.survophthal.2026.10.007_bib151","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00417-025-06890-x","article-title":"Management of fibrosis in neovascular age-related macular degeneration","volume":"264","author":"Chakravarthy","year":"2026","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.10.007_bib152","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41433-023-02848-7","article-title":"Clinical proof of concept for anti-FGF2 therapy in exudative age-related macular degeneration (nAMD): phase 2 trials in treatment-na\u00efve and anti-VEGF pretreated patients","volume":"38","author":"Pereira","year":"2024","journal-title":"Eye (Lond)"},{"issue":"14","key":"10.1016\/j.survophthal.2026.10.007_bib153","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.survophthal.2026.10.007_bib154","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202412366","article-title":"Rationally engineering pro-proteins and membrane-penetrating \u03b1\u2011helical polypeptides for genome editing toward choroidal neovascularization treatment","volume":"37","author":"Liu","year":"2025","journal-title":"Adv Mater"},{"key":"10.1016\/j.survophthal.2026.10.007_bib155","article-title":"ROS-responsive drug delivery system with enhanced anti-angiogenic and anti-inflammatory properties for neovascular age-related macular degeneration therapy","volume":"32","author":"Zuo","year":"2025","journal-title":"Mater Today Bio"},{"issue":"8","key":"10.1016\/j.survophthal.2026.10.007_bib156","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/iovs.65.8.31","article-title":"Cell-penetrating chaperone nuc1 for small- and large-molecule delivery into retinal cells and tissues","volume":"65","author":"Kumar","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726001499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726001499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:43:28Z","timestamp":1793364208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625726001499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":156,"alternative-id":["S0039625726001499"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.10.007","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subretinal fibrosis in neovascular age-related macular degeneration: From clinical features to fibrotic mechanisms and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}